Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is 3.004.348,45 ₫, with a 24-hour trading volume of 7,94B ₫. The asset's market cap is 7,42P ₫, after moving 0.88% in the last day.
Tokenized Merck & Co Inc is trading at 3.001.478,17 ₫, with a tokenized market cap of 22,11B ₫ and a 24-hour trading volume of 26,17B ₫. The tokenized asset has moved -2.62% in the past 24 hours.